Greg Lucier, chairman and CEO of Invitrogen, will assume that same role following consummation of the firm’s merger with Applied Biosystems, expected to close in the fall. Mark Stevenson, currently president and COO of ABI, will retain that role in the merged company, which will keep the ABI name. Tony White, chairman, president, and CEO of ABI parent Applera, will serve as a consultant to ABI following the deal.
Gene Express has appointed Michael Rowe to be senior VP of global marketing.
Rowe formerly was director of cardiovascular marketing at Women First Healthcare, senior marketing director at Pfizer, director of global outcomes research and strategic marketing at Allergan, and manager of international marketing and marketing research at Warner-Lambert Company.